ATE291425T1 - R-eliprodil zur behandlung von glaucoma - Google Patents

R-eliprodil zur behandlung von glaucoma

Info

Publication number
ATE291425T1
ATE291425T1 AT01937291T AT01937291T ATE291425T1 AT E291425 T1 ATE291425 T1 AT E291425T1 AT 01937291 T AT01937291 T AT 01937291T AT 01937291 T AT01937291 T AT 01937291T AT E291425 T1 ATE291425 T1 AT E291425T1
Authority
AT
Austria
Prior art keywords
eliprodil
glaucoma
treatment
treating glaucoma
agents
Prior art date
Application number
AT01937291T
Other languages
English (en)
Inventor
Michael A Kapin
Michael V W Bergamini
Verney L Sallee
Original Assignee
Alcon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Inc filed Critical Alcon Inc
Application granted granted Critical
Publication of ATE291425T1 publication Critical patent/ATE291425T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Toxicology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT01937291T 2000-05-10 2001-05-10 R-eliprodil zur behandlung von glaucoma ATE291425T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20335000P 2000-05-10 2000-05-10
PCT/US2001/015169 WO2001085169A2 (en) 2000-05-10 2001-05-10 R-eliprodil for treating glaucoma

Publications (1)

Publication Number Publication Date
ATE291425T1 true ATE291425T1 (de) 2005-04-15

Family

ID=22753611

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01937291T ATE291425T1 (de) 2000-05-10 2001-05-10 R-eliprodil zur behandlung von glaucoma

Country Status (7)

Country Link
EP (1) EP1280528B1 (de)
JP (1) JP2004521065A (de)
AT (1) ATE291425T1 (de)
AU (2) AU2001261360A1 (de)
CA (1) CA2406549A1 (de)
DE (1) DE60109594D1 (de)
WO (2) WO2001085152A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0212151A (pt) * 2001-08-29 2004-08-24 Alcon Inc Uso de compostos para tratar condições resultantes de dano ao nervo corneano após cirurgias de lasik e outras oculares ou traumas
US6884816B2 (en) 2001-08-31 2005-04-26 Alcon, Inc. Hydroxy substituted fused naphthyl-azoles and fused indeno-azoles and their use for the treatment of glaucoma
CA2506204A1 (en) 2002-12-13 2004-07-01 Alcon, Inc. Novel benzopyran analogs and their use for the treatment of glaucoma
US7476687B2 (en) 2003-11-26 2009-01-13 Alcon, Inc. Substituted furo[2,3-g]indazoles for the treatment of glaucoma
US7338972B1 (en) 2003-12-15 2008-03-04 Alcon, Inc. Substituted 1-alkylamino-1H-indazoles for the treatment of glaucoma
WO2005058911A2 (en) 2003-12-15 2005-06-30 Alcon, Inc. Substituted [1,4]oxazino[2,3-g]indazoles for the treatment of glaucoma

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2628740B3 (fr) * 1989-04-12 1990-01-19 Synthelabo Procede de preparation des enantiomeres du (chloro-4 phenyl)-1 (((fluoro-4 phenyl)methyl)-4 piperidyl-1)-2 ethanol
FR2654341B1 (fr) * 1989-11-14 1994-09-23 Synthelabo Utilisation d'ifenprodil et de ses derives pour la fabrication de medicaments antipsychotiques.
US5710165A (en) * 1994-07-06 1998-01-20 Synthelabo Use of polyamine antagonists for the treatment of glaucoma
EP1057486A1 (de) * 1995-11-17 2000-12-06 Alcon Laboratories, Inc. Verwendung einer Medikamentenkombination zur Behandlung von Glaukom
JP2002521332A (ja) * 1998-07-21 2002-07-16 メルク エンド カムパニー インコーポレーテッド 高眼圧治療用眼薬組成物
AU5114499A (en) * 1998-07-21 2000-02-14 Merck & Co., Inc. Ophthalmic compositions for treating ocular hypertension

Also Published As

Publication number Publication date
WO2001085169A2 (en) 2001-11-15
AU2001261360A1 (en) 2001-11-20
WO2001085169A3 (en) 2002-03-28
WO2001085152A2 (en) 2001-11-15
EP1280528A2 (de) 2003-02-05
JP2004521065A (ja) 2004-07-15
WO2001085152A3 (en) 2002-03-28
EP1280528B1 (de) 2005-03-23
DE60109594D1 (de) 2005-04-28
AU2001263042A1 (en) 2001-11-20
CA2406549A1 (en) 2001-11-15

Similar Documents

Publication Publication Date Title
NO20054988D0 (no) Preparater og metoder for behandling av cancer
DE60022917D1 (de) Reboxetin zur Behandlung von Migränekopfschmerzen
ATE350030T1 (de) Nordihydroguaiaretinsäurederivate zur behandlung von tumoren
DE69833971D1 (de) Verfahren zur behandlung von alzheimerschen krankheit
DE60015070D1 (de) Verwendung von antikonvulsiven derivaten zur behandlung der cluster headache
DE60120667D1 (de) Methoden und mittel zur behandlung von bandscheibenverschleiss
DE60123276D1 (de) Piperazinderivate zur behandlung bakterieller infektionen
DE60330161D1 (de) Rifalazil zur behandlung von infektionen mit clostridium difficile
DE69929464D1 (de) Zyklische polyamine zur behandlung der thrombozytopenie
DE60136477D1 (de) Retinoide zur behandlung von emphysem
ATE415163T1 (de) Verfahren und zusammensetzungen zur behandlung von augenerkrankungen
ATE541565T1 (de) Topische verwendung von muskarinischen und opioiden mitteln zur behandlung von tinnitus
EP1506001A4 (de) Verfahren und zusammensetzungen zur behandlung von epithelläsionen in vagina, zervix und uterus
DE60206289D1 (de) Verwendung von bibn4096 in kombination mit anderen migränemitteln zur behandlung von migräne
IL161501A0 (en) Methods of preventing and treating flavivirus infection in animals
DE50114605D1 (de) No-thien-2-yl-essigsaure-derivate und ihre verwendung zur behandlung von migraine bzw. schmerz
DE60218153D1 (de) Verwendung von proteasom-inhibitoren zur behandlung des trockenen auges
DE60109594D1 (de) R-eliprodil zur behandlung von glaucoma
ATE347888T1 (de) Verwendung von aivlosin zur behandlung und prevention der lawsonia-infektionen in schweinen.
ATE359808T1 (de) Verwendung von sarp-1 zur behandlung und/oder vorbeugung von scleroderma
ATE422944T1 (de) Superoxiddismutas-mimetika zur behandlung von augenerkrankungen
ATE406171T1 (de) Aplidine zur behandlung von multiplem myelom
DE60142786D1 (de) Zusammensetzungen und methoden zur behandlung von candidosen
DE69818809D1 (de) Verfahren zur behandlung von narbengewebe
ATE278401T1 (de) Verwendung von riluzol zur behandlung von akustischen traumazuständen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties